PMID: 8595752Mar 1, 1996Paper

Total hip replacement in dysplastic hips using femoral head shelf autografts

Clinical Orthopaedics and Related Research
E MorsiA E Gross

Abstract

A consecutive series of 30 dysplastic hips were treated with total hip arthroplasty using femoral head autograft shelf reconstruction and were reviewed. Cemented cups were used in 13 hips and uncemented cups were used in 17 hips. The average followup was 8.1 years (range, 5.2-13.3 years). In the cemented group, the average preoperative Harris Hip Score was 44.8 points (range, 22-82 points), and in the uncemented group, it was 45 points (range, 23-61 points). At the final review, the average clinical score was 71.5 points (range, 46-98 points) in the cemented group, and in the uncemented group it was 87.5 points (range, 63-100 points). Of the 30 cases, only 3 had unsuccessful results, giving a success rate of 90%. In terms of the autograft, all united to host bone. Resorption, when seen in either cemented or uncemented cups, was minor and restricted to the lateral nonweightbearing part of the graft. The present study supports using shelf autografts to reconstruct dysplastic hips at the time of total hip arthroplasty. In this series, cemented and uncemented cups performed equally well.

References

May 1, 1991·The Journal of Bone and Joint Surgery. British Volume·H FredinL Unander-Scharin

❮ Previous
Next ❯

Citations

Jul 29, 2005·The Journal of Bone and Joint Surgery. British Volume·G MoragA E Gross
Dec 28, 1999·Clinical Orthopaedics and Related Research·A E Gross
Jan 13, 2015·Archives of Orthopaedic and Trauma Surgery·Kiyokazu FukuiTadami Matsumoto
Sep 7, 2002·The Journal of Arthroplasty·A Hashemi-NejadA Catterall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.